Long-Term Benefits, Risks of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with RA Nan Yang, PharmD, & Kurt Oelke, MD, on behalf of the ARHP Practice Committee | Issue: December 2017 | December 19, 2017 Page: 1 2 3 4 5 | Single Page Share: